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Sirs: Autonomic dysfunction is a
common feature of multiple sys-
tem atrophy (MSA). It can be
incapacitating for patients, leading
to urinary urge, severe constipa-
tion, altered sweating, and ortho-
static hypotension with falls due to
syncope [1]. Here, we present an
unusual complication of auto-
nomic dysfunction in a patient
with deﬁnite MSA that came to
light during the unusual hot
summer of 2003 in the Nether-
lands.
A sixty-six year old man with a
four year history of bladder
hypocontractility, and a one year
history of orthostatic hypotension,
was referred to our Department of
Neurology for further evaluation.
The patient’s main subjective
complaint was lightheadedness
while walking the stairs. He did
not report muscle stiffness or
slowness when walking. His
upright posture had become
slightly stooped during the
preceding year. He further
complained of a dry mouth, being
unable to sweat, impotence, and
problems with swallowing.
When ﬁrst seen by us in
March 2002, neurological exami-
nation revealed marked ortho-
static hypotension (supine: 150/90
mm Hg; erect 3 minutes after
rising: 90/70 mm Hg), and slight
hypomimia of the face, but no
bradykinesia or hypokinesia of
the extremities. His voice was soft
and monotone. Posture was
slightly stooped, but gait was
normal. The arms displayed sub-
tle and symmetrical signs of
rigidity, with cogwheeling. There
was no resting tremor. The ret-
ropulsion test showed mild pos-
tural instability with a few steps
retropulsion, but unaided recov-
ery. Vibration sense in the lower
legs was absent, with a positive
Romberg sign. Tendon reﬂexes
were symmetrically brisk in both
the arms and legs, with Babinski
responses in both feet. The pa-
tient was diagnosed as having a
probable MSA of the striatonigral
subtype. In the following year, he
developed a marked, symmetrical
bradykinesia and rigidity. Levo-
dopa therapy was started and ti-
trated to a maximal dose of 750
mg/day, with an only minimal
improvement in his motor per-
formance. He also received
hydrocortisone to treat the
orthostatic hypotension.
Magnetic resonance imaging
of the brain showed slight gen-
eralized atrophy. [
123I]IBZM-
SPECT showed bilaterally
diminished striatal uptake, con-
sisting with dopamine D2-recep-
tor loss. Neurophysiological
examination showed signs of a
minor sensorimotor axonal
polyneuropathy.
During an unusually hot
summer period (by Dutch stan-
dards) in 2003, with temperatures
of 30 degrees Celsius, the patient
was admitted to our emergency
room because he had been
unconsciousness for four hours.
General physical examination re-
vealed a body temperature of 41
degrees Celsius, but the patient
was not sweating anywhere. Neu-
rological examination revealed
somnolence, with a Glasgow Coma
Score of Eyes = 4, motor re-
sponse = 6 and verbal re-
sponse = 2. There were no signs of
meningism or focal neurological
deﬁcits. Maligant neuroleptic syn-
drome was deemed very unlikely
on clinical grounds, because there
were no signs of extreme stiffness
(rigidity was comparable to what
we scored during an outpatient
clinic visit 3 months earlier).
Moreover, the patient was not
receiving any neuroleptics, and at
that time of the event levodopa
therapy had not yet been initiated,
so acute levodopa withdrawal or
treatment failure as possible cause
of malignant neuroleptic syn-
drome could be excluded.
Laboratory examination
showed no abnormalities, includ-
ing a normal leukocyte count
(9.1 · 10
9/l) and C-reactive pro-
tein (7 mg/l). A lumbar puncture
was performed with a normal
opening pressure (18 cm H2O), no
leukocytes, and a normal protein
and glucose content. Direct Gram
staining of the cerebral spinal ﬂuid
showed no microorganisms.
Radiographs of the chest showed
no inﬁltrates, a urinary culture
demonstrated no bacteria, and
blood cultures were negative. After
active cooling with external cool
pads, the body temperature rap-
idly decreased, and the patient
quickly recovered.
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formance further declined, and
levo-dopa therapy was initiated.
One year later, he died during his
sleep at a nursing home, probably
due to an aspiration pneumonia.
Post-mortem examination of the
brain was consisted with MSA of
the striatonigral degeneration
type.
Hypohidrosis or anhidrosis due
to loss of sweating function is a
known, but not often described
phenomenon of MSA [2–5].
Hyperthermia and subsequent loss
of consciousness due to anhidrosis
has been described occasionally,
but in this case the patient was
suffering from a concurrent
infection [6]. Our patient showed
no signs of underlying infection,
which suggests that the summer
heat – in combination with
anhidrosis – was the cause of his
hyperthermia. Although we did
not perform a formal sweating
test, both the patient’s history and
his physical examination were
consistent with this conclusion. A
malignant neuroleptic-like syn-
drome or acute akinesia as a pos-
sible explanation for his condition,
which has been recently described
by others [7], seems unlikely,
since there was no marked rigid-
ity. Furthermore, the patient was
not receiving any levodopa ther-
apy, dopamine agonists or neuro-
leptic drugs at the time of this
event or in the previous days.
Body temperature increases
when the rate of heat production
exceeds the rate of heat dissipa-
tion. Hyperthermia occurs when
thermoregulatory mechanisms are
overwhelmed by excessive meta-
bolic production of heat, excessive
environmental heat, or impaired
heat dissipation. In hyperthermic
states, the hypothalamic set-point
is normal but peripheral mecha-
nisms are unable to maintain a
body temperature that matches
the set-point [8]. In our patient,
hyperthermia was caused by a
combination of excessive envi-
ronmental heat and impaired heat
dissipation due to hypohidrosis.
Hypohidrosis in MSA is probably
caused by both post- and pregan-
glionic sudomotor failure [5], and
a decreased potentiation of calci-
tonin gene related peptide
(CGRP)-induced cholinergic sweat
production [9]. It is possible that
levodopa can further aggravate
autonomic problems [10], but
anhidrosis or heat stroke have not
been described as adverse effects
of levodopa.
Physicians should instruct
patients with MSA and clear
autonomic signs, in particular
when this includes of hypo- or
anhidrosis, to avoid extreme heat,
and especially when suffering
from an infection. When present,
this hyperthermia must be rapidly
treated by cooling the body with
external cooling pads, and antibi-
otic therapy when necessary.
References
1. Gilman S, Low PA, Quinn N, et al.
(1999) Consensus statement on the
diagnosis of multiple system atrophy.
J Neurol Sci 163:94–98
2. Shy GM, Drager GA (1960) A neuro-
logical syndrome associated with
orthostatic hypotension. Arch Neurol
2:511–527
3. Cohen J, Low P, Fealey R, Sheps S,
Jiang NS (1987) Somatic and auto-
nomic function in progressive auto-
nomic failure and multiple system
atrophy. Ann Neurol 22:692–699
4. De Marinis M, Argenta G, Mele D,
Carbone A, Bafﬁgo G, Agnoli A (1993)
Evaluation of vesico-urethral and
sweating function in disorders pre-
senting with parkinsonism. Clin Auton
Res 3:125–130
5. Kihara M, Sugenoya J, Takahashi A
(1991) The assessment of sudomotor
dysfunction in multiple system
atrophy. Clin Auton Res 1:297–302
6. Yamamoto K, Morita S, Ikeda S,
Yanagisawa N (1993) Hyperthermia in
a Shy-Drager syndrome patient –
pathophysiological effects of body
temperature and L-DOPS on ortho-
static hypotension. Rinsho Shinkeigaku
33:68–73
7. Onofrj M, Thomas A (2005) Acute
akinesia in Parkinson disease. Neurol-
ogy 64:1162–1169
8. Simon HB (1993) Hyperthermia. N
Engl J Med 329:483–487
9. Kumazawa K, Sobue G, Mitsuma T,
Sugenoya J, Ogawa T (1997) Impair-
ment of calcitonin gene-related
peptide-induced potentiation of cho-
linergic sweat secretion in patients with
multiple system atrophy. Clin Auton
Res 7:77–80
10. van Dijk JG, Haan J, Zwinderman K,
Kremer B, van Hilten BJ, Roos RA
(1993) Autonomic nervous system
dysfunction in Parkinson’s disease:
relationships with age, medication,
duration, and severity. J Neurol Neu-
rosurg Psychiatry 56:1090–1095
665